Brad Willock HOLDRs Pharmaceutical PPH-N TOP PICK Sep 03, 2003

A diversified way he can play the pharmaceutical sector. Good exposure for retail investors. This is a 1 to 3 year play.

Brad Willock

Owned

Unlock Rating

$74.760

Stock price when the opinion was issued

biotechnology

It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

Get Signals Create your Watchlist

You might be interested:

PAST TOP PICK

(A top pick Sept 3/03. Up 2%.) Feels that 2004 will be a better time for pharmaceuticals. The stock is a good way for investors to lower their risk and play a decent value situation.

PAST TOP PICK

(Past top pick December 5, up 11%) Will continue to play out.

COMMENT

If you like the biotechnology/pharmaceutical sector, this is a good ETF. One of the ways investors tend to do that kind of a trade is to buy a small portion of the portfolio in the ETF itself and sprinkler around it 2 or 3 stocks that they think will do quite well.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.

Brad Willock HOLDRs Pharmaceutical PPH-N TOP PICK Sep 03, 2003

You might be interested:

HOLDRs Pharmaceutical(PPH-N)

HOLDRs Pharmaceutical(PPH-N)

HOLDRs Pharmaceutical(PPH-N)

Latest Buy Signals

Today's Top Picks

Popular Articles

Latest Sell Signals

Most Recent Experts

Bruce Murray

The Panic-Proof Portfolio (Stockchase Research)

The Weekly Buzzing Stocks by Billy Kawasaki

Chris Blumas

Stockchase Insights